Related references
Note: Only part of the references are listed.In Vivo AAV-CRISPR/Cas9-Mediated Gene Editing Ameliorates Atherosclerosis in Familial Hypercholesterolemia
Huan Zhao et al.
CIRCULATION (2020)
What's in a name? Renaming 'NAFLD' to 'MAFLD'
Yasser Fouad et al.
LIVER INTERNATIONAL (2020)
The Associations between Liver Enzymes and Cardiovascular Risk Factors in Adults with Mild Dyslipidemia
Eun-Ock Park et al.
JOURNAL OF CLINICAL MEDICINE (2020)
The Relationship between Serum Alkaline Phosphatase and Arterial Stiffness in Korean Adults
Jun-Hyuk Lee et al.
JOURNAL OF ATHEROSCLEROSIS AND THROMBOSIS (2019)
Elevated liver enzymes and cardiovascular mortality: a systematic review and dose-response meta-analysis of more than one million participants
Jamal Rahmani et al.
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY (2019)
Acetaldehyde dehydrogenase 2 interactions with LDLR and AMPK regulate foam cell formation
Shanshan Zhong et al.
JOURNAL OF CLINICAL INVESTIGATION (2019)
Guidelines of prevention and treatment of nonalcoholic fatty liver disease (2018, China)
Jian Gao Fan et al.
JOURNAL OF DIGESTIVE DISEASES (2019)
Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention
Zobair Younossi et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2018)
Hyperlipidemia induces typical atherosclerosis development in Ldlr and Apoe deficient rats
Yongliang Zhao et al.
ATHEROSCLEROSIS (2018)
Gamma-glutamyl transferase and the risk of atherosclerosis and coronary heart disease
Gjin Ndrepepa et al.
CLINICA CHIMICA ACTA (2018)
Validation of LDLr Activity as a Tool to Improve Genetic Diagnosis of Familial Hypercholesterolemia: A Retrospective on Functional Characterization of LDLr Variants
Asier Benito-Vicente et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
Non-invasive assessment of non-alcoholic fatty liver disease: Clinical prediction rules and blood-based biomarkers
Eduardo Vilar-Gomez et al.
JOURNAL OF HEPATOLOGY (2018)
Serum gamma-glutamyl transferase is a predictor of mortality in patients with acute myocardial infarction
Jae Gyung Kim et al.
MEDICINE (2018)
Mechanisms of NAFLD development and therapeutic strategies
Scott L. Friedman et al.
NATURE MEDICINE (2018)
Implication of liver enzymes on incident cardiovascular diseases and mortality: A nationwide population-based cohort study
Kyung Mook Choi et al.
SCIENTIFIC REPORTS (2018)
Serum Gamma-Glutamyltransferase Levels are Associated with Cardiovascular Risk Factors in China: A Nationwide Population-Based Study
Dan-Dan Li et al.
SCIENTIFIC REPORTS (2018)
New trends on obesity and NAFLD in Asia
Jian-Gao Fan et al.
JOURNAL OF HEPATOLOGY (2017)
Alkaline phosphatase: a novel treatment target for cardiovascular disease in CKD
Mathias Haarhaus et al.
NATURE REVIEWS NEPHROLOGY (2017)
Gamma-glutamyltransferase and risk of cardiovascular mortality: A dose-response meta-analysis of prospective cohort studies
Junna Wang et al.
PLOS ONE (2017)
Gamma-glutamyltransferase and cardiovascular mortality in Korean adults: A cohort study
Sang-Wook Yi et al.
ATHEROSCLEROSIS (2017)
Gamma-glutamyl transferase and prognosis in patients with coronary artery disease
Gjin Ndrepepa et al.
CLINICA CHIMICA ACTA (2016)
The economic and clinical burden of nonalcoholic fatty liver disease in the United States and Europe
Zobair M. Younossi et al.
HEPATOLOGY (2016)
NAFLD: A multisystem disease
Christopher D. Byrne et al.
JOURNAL OF HEPATOLOGY (2015)
Exome sequencing identifies rare LDLR and APOA5 alleles conferring risk for myocardial infarction
Ron Do et al.
NATURE (2015)
Liver enzymes and risk of cardiovascular disease in the general population: A meta-analysis of prospective cohort studies
Setor K. Kunutsor et al.
ATHEROSCLEROSIS (2014)
Associations between γ-glutamyltransferase (GGT) and biomarkers of atherosclerosis: The multi-ethnic study of atherosclerosis (MESA)
Ryan D. Bradley et al.
ATHEROSCLEROSIS (2014)
Prevalence of the TM6SF2 variant and non-alcoholic fatty liver disease in Chinese
Vincent Wai-Sun Wong et al.
JOURNAL OF HEPATOLOGY (2014)
Targeted Disruption of LDLR Causes Hypercholesterolemia and Atherosclerosis in Yucatan Miniature Pigs
Bryan T. Davis et al.
PLOS ONE (2014)
Associations between total serum GGT activity and metabolic risk: MESA
Ryan Bradley et al.
BIOMARKERS IN MEDICINE (2013)
被撤回的出版物: World Medical Association Declaration of Helsinki Ethical Principles for Medical Research Involving Human Subjects (Retracted article. See vol. 135, pg. 2149, 2021)
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2013)
Gamma-glutamyltransferase is associated with cardiovascular and all-cause mortality: A meta-analysis of prospective cohort studies
Guangli Du et al.
PREVENTIVE MEDICINE (2013)
Serum γ-Glutamyltranspeptidase Predicts All-cause, Cardiovascular and Liver Mortality in Older Adults
Rohit Loomba et al.
JOURNAL OF CLINICAL AND EXPERIMENTAL HEPATOLOGY (2013)
Gamma-glutamyltransferase and risk of cardiovascular disease mortality in people with and without diabetes: Pooling of three British Health Surveys
Andre Pascal Kengne et al.
JOURNAL OF HEPATOLOGY (2012)
Association of Genetic Variants Influencing Lipid Levels with Coronary Artery Disease in Japanese Individuals
Fumihiko Takeuchi et al.
PLOS ONE (2012)
Cardiovascular risk factors and γ-glutamyltransferase fractions in healthy individuals
Maria Franzini et al.
CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2010)
Genetic Variants Associated With Myocardial Infarction Risk Factors in Over 8000 Individuals From Five Ethnic Groups The INTERHEART Genetics Study
Sonia S. Anand et al.
CIRCULATION-CARDIOVASCULAR GENETICS (2009)
Elevated serum alkaline phosphatase and peripheral arterial disease in the United States National Health and Nutrition Examination Survey 1999-2004
Bernard M. Y. Cheung et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2009)
Longitudinal change in serum gamma-glutamyltransferase and cardiovascular disease mortality - A prospective population-based study in 76 113 Austrian adults
Alexander M. Strasak et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2008)
Genetic variation at the LDL receptor and HMG-CoA reductase gene loci, lipid levels, statin response, and cardiovascular disease incidence in PROSPER
Eliana Polisecki et al.
ATHEROSCLEROSIS (2008)
Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease
Stefano Romeo et al.
NATURE GENETICS (2008)
Quantitative effects of common genetic variations in the 3'UTR of the human LDL-receptor gene and their associations with plasma lipid levels in the Atherosclerosis Risk in Communities study
Hind Muallem et al.
HUMAN GENETICS (2007)
Gamma glutamyltransferase and long-term survival: Is it just the liver?
Lili Kazemi-Shirazi et al.
CLINICAL CHEMISTRY (2007)
Gamma glutamyl transferase and metabolic syndrome, cardiovascular disease, and mortality risk - The Framingham Heart Study
Douglas S. Lee et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2007)